Global Digital Signature Market to Reach $2,934.6 Million by 2023     |    Global Outdoor Lighting Market to Witness 8.4% CAGR during 2017 - 2023     |    Oral Mucositis Therapeutics Pipeline to Receive More Drug Designations from the USFDA in the Coming Years

Toll Free (US/Canada): 1-888-778-7886

INT'L: 1-347-960-6455

enquiry@psmarketresearch.com

Disposable Plastic Blood Bag Market

P&S Market Research-Disposable Plastic Blood Bag Market report

Global Disposable Plastic Blood Bag Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, and Quadruple Blood Bag), and by End-User (Hospital, Blood Bank, and Home Healthcare)

Published: October 2015
Report Code: LS10439
Available Format: pdf
Pages: 104
Category : Healthcare

The global disposable plastic blood bag market accounted for $286.5 million in 2014, and it is expected to grow with a CAGR of 9.2% during 2015-2020. The single disposable plastic blood bag segment dominated the market with about 75% share in 2014. Among end-user, hospital is the largest and fastest growing segment in the disposable plastic blood bag market.

Disposable Plastic Blood Bag Market

Disposable plastic blood bag market is escalating with high growth rate due to due to increasing prevalence of chronic diseases and growing aging population. In addition, rising initiatives undertaken by government associations to boost awareness about blood donations and advanced features of disposable plastic blood bags are also supporting to the growth of this market.

Disposable plastic blood bags are bio-medical devices which are used in the collection and transportation of human blood. In addition, disposable plastic blood bags bags also help in the separation of blood components, such as platelets, plasma and cryoprecipitate, that are used to treat a range of blood disorders. These bags consist of a single pouch or multiple pouches connected with tubes, needles, and clamps that help in the collection of blood and blood components. Disposable plastic blood bags have completely replaced glass bottles for collection and transportation of blood. This is due to excessive cleaning and autoclaving requirements of glass bottles.

The restraints associated with the global disposable plastic blood bag market include the undeveloped blood collection and storage infrastructure in developing countries and high risk associated with blood donation and transfusion. Specific environmental conditions are very essential for storage of blood and its components and to maintain them in their usable form. However, remote areas of developing countries, such as India and China, have inadequate storage conditions for the donated blood. In addition, irregular and compromised use of sterilized needles and bags increases the risk of infection and sepsis contraction. Increasing numbers of mergers and acquisitions activity and increasing usage of radiofrequency identification (RFID) technology in blood bags are some of the major trends observed in the market.

Geographically, North America is expected to maintain its dominance in the global disposable plastic blood bag market during 2015 - 2020. This is due to growing R&D activities in the blood transfusion technique and increasing prevalence of blood disorders in the region. Europe is expected to witness marginal growth in this market in near future. However, the Asian region is expected to witness the highest growth globally during the forecast period. This is mainly due to growing aging population, increasing prevalence of blood disorders, and initiatives taken by government to improve condition of patients suffering from blood disorders.

The key companies operating in the global disposable plastic Blood bag market include Haemonetics Corporation, JMS Co., Ltd., Kawasumi Laboratories, Inc., Grifols International S.A., AdvaCare Pharma, Fresenius SE & Co. KGaA, Terumo Corporation, Macopharma, Genesis BPS, SURU International Pvt. Ltd., Shanghai Transfusion Technology Co., Ltd., Nigale Biomedical Inc. of Sichuan Province Corporation (Nigale), Neomedic Limited, and Shandong Weigao Group Medical Polymer Company Limited.

Place An Order

Single User License

Single User License authorizes access of the publication to single user, i.e. the buyer of the report.

5100
Group License

Group License authorizes access of the publication upto 5 users.

6100
Site License

Site License authorizes access of the publication to all the employees of the organization at a single geographic location.

7100
Enterprise License

Enterprise License provides right to distribute copies of the publication across the organization and its subsidiaries.

9100
down-arrow

Pre-Purchase Enquiry


 

Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Center : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment